Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aleplasinin (PAZ 417) is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 29,000 | |||
5 mg | 在庫あり | ¥ 72,000 | |||
10 mg | 在庫あり | ¥ 118,000 | |||
25 mg | 在庫あり | ¥ 192,000 | |||
50 mg | 在庫あり | ¥ 266,500 | |||
100 mg | 在庫あり | ¥ 358,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 83,500 |
説明 | Aleplasinin (PAZ 417) is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies. |
別名 | PAZ 417, PAZ417, PAZ-417 |
分子量 | 425.52 |
分子式 | C28H27NO3 |
CAS No. | 481629-87-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (575.77 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aleplasinin 481629-87-2 Metabolism PAI-1 Plasminogen activator inhibitor-1 Serpin family PAZ 417 Abeta inhibit PAZ417 Inhibitor Amyloid-β Alzheimer's disease BBB-penetrated β-amyloid peptide orally active PAZ-417 memory deficiency inhibitor